Loading
A phase 2/3 trial of carboplatin, paclitaxel / nab-paclitaxel, doxorubicin, cyclophosphamide and other drugs in triple-negative breast cancer, run by The Netherlands Cancer Institute, active but no longer recruiting.
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer is a phase 2/3, randomised interventional study registered as NCT01057069 by The Netherlands Cancer Institute, with a registry enrolment figure of 310 participants, started 2010-01 and due to reach its primary completion in 2023-06. Interventions recorded: Carboplatin and Paclitaxel; Doxorubicin, cyclophosphamide; Doxorubicin, cyclophosphamide, carboplatin, thiotepa, cyclophosphamide. Conditions listed: Breast Cancer. Sites: Netherlands. No results are recorded here; the registry entry is the source.
Shares Cyclophosphamide, Doxorubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Cyclophosphamide, Doxorubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Cyclophosphamide, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.
Shares Cyclophosphamide, Doxorubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Cyclophosphamide, Doxorubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Paclitaxel / nab-paclitaxel and the tag tnbc-deep-dive.
Shares Cyclophosphamide, Doxorubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Cyclophosphamide, Doxorubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.